These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35214741)

  • 1. Autochthonous Outbreak of SARS-CoV-2 Omicron Variant in Booster-Vaccinated (3 Doses) Healthcare Workers in Southern Italy: Just the Tip of the Iceberg?
    Loconsole D; Bisceglia L; Centrone F; Sallustio A; Accogli M; Dalfino L; Brienza N; Chironna M
    Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy.
    Loconsole D; Sallustio A; Accogli M; Leaci A; Sanguedolce A; Parisi A; Chironna M
    Clin Microbiol Infect; 2021 Aug; 27(8):1174.e1-1174.e4. PubMed ID: 33984489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary SARS-CoV-2 Infections, Re-infections and Vaccine Effectiveness during the Omicron Transmission Period in Healthcare Workers of Trieste and Gorizia (Northeast Italy), 1 December 2021-31 May 2022.
    Cegolon L; Negro C; Mastrangelo G; Filon FL;
    Viruses; 2022 Nov; 14(12):. PubMed ID: 36560692
    [No Abstract]   [Full Text] [Related]  

  • 4. Characteristics of the First 284 Patients Infected with the SARS-CoV-2 Omicron BA.2 Subvariant at a Single Center in the Apulia Region of Italy, January-March 2022.
    Loconsole D; Centrone F; Sallustio A; Accogli M; Casulli D; Sacco D; Zagaria R; Morcavallo C; Chironna M
    Vaccines (Basel); 2022 Apr; 10(5):. PubMed ID: 35632430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multistate Outbreak of SARS-CoV-2 B.1.1.529 (Omicron) Variant Infections Among Persons in a Social Network Attending a Convention - New York City, November 18-December 20, 2021.
    Smith-Jeffcoat SE; Pomeroy MA; Sleweon S; Sami S; Ricaldi JN; Gebru Y; Walker B; Brady S; Christenberry M; Bart S; Vostok J; Meyer S; Seys S; Markelz A; Ditto N; Newbern V; Thomas FJ; Thomas D; Cabredo E; Kellner S; Brown VR; Tate JE; Kirking HL
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(7):238-242. PubMed ID: 35176004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection of healthcare workers despite a high vaccination rate during the fifth wave of COVID-19 due to Omicron variant in Hong Kong.
    Wong SC; Chan VW; Yuen LL; AuYeung CH; Leung JO; Li CK; Kwok MO; So SY; Chen JH; Chiu KH; Tam AR; Hung IF; Kai-Wang To K; Lo JY; Yuen KY; Cheng VC
    Infect Prev Pract; 2023 Mar; 5(1):100261. PubMed ID: 36465098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Responses against the Omicron Variant of SARS-CoV-2 after a Third Dose of COVID-19 Vaccine in Patients Living with Human Immunodeficiency Virus (PLWH): Comparison with Healthcare Workers.
    Park JH; Chung H; Kim MC; Choi SH; Chung JW
    Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare Workers' Knowledge and Perception of the SARS-CoV-2 Omicron Variant: A Multinational Cross-Sectional Study.
    Bhagavathula AS; Mahabadi MA; Tesfaye W; Nayar KR; Chattu VK
    Healthcare (Basel); 2022 Feb; 10(3):. PubMed ID: 35326916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and outcomes of vaccinated and nonvaccinated patients hospitalized in a single Italian hub for COVID-19 during the Delta and Omicron waves in Northern Italy.
    Rovida F; Esposito GL; Rissone M; Novelli V; Cutti S; Muzzi A; Rona C; Bertoli E; Daglio M; Piralla A; Paolucci S; Campanini G; Ferrari G; Giardina F; Zavaglio F; Lilleri D; Grugnetti AM; Grugnetti G; Odone A; Marena C; Baldanti F
    Int J Infect Dis; 2022 Sep; 122():420-426. PubMed ID: 35750265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Breakthrough Infection after mRNA-1273 Booster among CoronaVac-Vaccinated Healthcare Workers.
    Santi T; Kamarga L; De Samakto B; Jo J
    Infect Chemother; 2022 Dec; 54(4):774-780. PubMed ID: 36596685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of vaccination versus hybrid immunity against infection with COVID-19 Omicron variants among Health-Care Workers.
    Ntziora F; Kostaki EG; Karapanou A; Mylona M; Tseti I; Sipsas NV; Paraskevis D; Sfikakis PP
    Vaccine; 2022 Nov; 40(50):7195-7200. PubMed ID: 36150972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Autochthonous Outbreak of the SARS-CoV-2 P.1 Variant of Concern in Southern Italy, April 2021.
    Loconsole D; Sallustio A; Centrone F; Casulli D; Ferrara MM; Sanguedolce A; Accogli M; Chironna M
    Trop Med Infect Dis; 2021 Aug; 6(3):. PubMed ID: 34449757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid Immunity and the Incidence of SARS-CoV-2 Reinfections during the Omicron Era in Frontline Healthcare Workers.
    Chivu CD; Crăciun MD; Pițigoi D; Aramă V; Luminos ML; Jugulete G; Nițescu VG; Lescaie A; Apostolescu CG; Streinu Cercel A
    Vaccines (Basel); 2024 Jun; 12(6):. PubMed ID: 38932411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Spread of SARS-CoV-2 Variant Omicron with a Doubling Time of 2.0-3.3 Days Can Be Explained by Immune Evasion.
    Grabowski F; Kochańczyk M; Lipniacki T
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, risk factors, and vaccine effectiveness for SARS-CoV-2 infection among healthcare workers during the omicron pandemic in Shanghai, China.
    Wang D; Zhu D; Xia M; Wang X; Zou N
    Heliyon; 2024 Jun; 10(11):e32182. PubMed ID: 38947465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Has Omicron Changed the Evolution of the Pandemic?
    Lundberg AL; Lorenzo-Redondo R; Ozer EA; Hawkins CA; Hultquist JF; Welch SB; Prasad PVV; Oehmke JF; Achenbach CJ; Murphy RL; White JI; Havey RJ; Post LA
    JMIR Public Health Surveill; 2022 Jan; 8(1):e35763. PubMed ID: 35072638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022.
    Raju MK; Vivian Thangaraj JW; Selvavinayagam TS; Somasundaram A; Parthipan K; Sivadoss R; Sabarinathan R; Subramaniam S; A Rozario AG; Rani SD; Suganya E; Murhekar MV
    Indian J Med Res; 2022 Jan; 155(1):165-170. PubMed ID: 35417991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Household transmission of the SARS-CoV-2 Omicron variant in Denmark.
    Lyngse FP; Mortensen LH; Denwood MJ; Christiansen LE; Møller CH; Skov RL; Spiess K; Fomsgaard A; Lassaunière R; Rasmussen M; Stegger M; Nielsen C; Sieber RN; Cohen AS; Møller FT; Overvad M; Mølbak K; Krause TG; Kirkeby CT
    Nat Commun; 2022 Sep; 13(1):5573. PubMed ID: 36151099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Omicron Variant in Croatia-Rapid Detection of the First Case and Cross-Border Spread.
    Ferenčak I; Obrovac M; Žmak L; Kuzle J; Petrović G; Vilibić-Čavlek T; Jurić D; Jurić A; Hruškar Ž; Capak K; Stevanović V; Milanović M; Govedarica M; Vujošević D; Tabain I
    Pathogens; 2022 Apr; 11(5):. PubMed ID: 35631032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inappropriate risk perception for SARS-CoV-2 infection among Italian HCWs in the eve of COVID-19 pandemic.
    Riccò M; Vezzosi L; Balzarini F; Bragazzi NL
    Acta Biomed; 2020 May; 91(3):e2020040. PubMed ID: 32921735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.